localizes with lysosomal marker, Lamp1 and the core member of retromer complex, Vps35.
Introduction
Lysosomes have traditionally been believed as a disposal organelle of the cell. A growing body 25 of recent studies have implicated lysosomes as centers of cellular nutrient recycling (Abu- 26 Remaileh et al., 2017; Korolchuk and Rubinsztein, 2011; Rabanal-Ruiz and Korolchuk, 2018) . 27 There are growing evidences that lysosomes regulate cellular homeostasis of various metals 28 point we could not determine whether the retrograde pathway of ATP7B can also originate 141 exclusively from lysosomal or late endosomal compartments. 142 It is worth mentioning that the size and shapes of the lysosomal compartments (Lamp1 +) are 143 variable across cells and as well as in a single cell. It varies from 20-200µM in diameter 144 (maximum length across) and shape varies from small puncta to larger patchy clumps. We did 145 not notice any correlationship between size and shape of the compartment with the treated 146 copper concentration or the passage number of the cell. To study if ATP7B co-localizes with retromer core components, cells were treated with either of 166 the 4 conditions described above. Cells were fixed, blocked and co-stained with anti-ATP7B and 
172
To further understand if retromer regulates any of these phases of ATP7B trafficking, we 173 knocked down VPS35 and studied the phenotype of copper induced localization of ATP7B with 174 respect to TGN. Appreciable knockdown was attained (>70-80%) for the targeted siRNAs as 175 compared to scrambled for VPS35 as ascertained by immunoblotting ( Fig. 5A ). Furthermore, as 
185
To corroborate our finding that VPS35 regulates ATP7B trafficking, we utilized the wild type and 186 the inactive dominant negative mutant mCherry-VPS35 (R107A) (gift from Dr, Sunando Datta, 187 IISER Bhopal). The R107A mutation abolishes the interaction of VPS35 with VPS26 and affects 188 cargo sorting. (Gokool et al. (2007) ; Zhao et al. (2007 ) . Cells were co-transfected with GFP-189 ATP7B and mCherry-wt-VPS35 and GFP-ATP7B was concentrated at TGN (perinuclear region) 190 with copper chelator. Vesicularization and recycling of ATP7B was triggered with treatment with 191 copper. Image capture was initiated at the point of copper treatment and data was collected at 192 an interval of 1.93 second for a total period of 30 mins. We noticed that within 1 min of Cu Since we determined that ATP7B colocalizes at the lysosomes at high copper, we investigated 199 if VPS35 regulates lysosomal exit of ATP7B on triggering its retrograde pathway. Using identical 200 experimental conditions of knocking down VPS35, we found that ATP7B is arrested at lysosome 201 upon triggering the retrograde pathway (i.e., high copper > BCS) ( Fig. 5D ). Interestingly, 202 boosting the retrograde pathway by lengthening BCS treatment time to 2h did not facilitate 203 retrieval of ATP7B from the lysosomes (Fig. 5D ). Also, in VPS35 kd cells, a population of ATP7B . 206 We confirmed the role of retromer by rescuing the non-recycling phenotype of ATP7B in VPS35 207 kd cells by overexpressing mcherry-wt-VPS35. We found that ATP7B recycled back from 208 vesicular to its tight perinuclear TGN localization upon copper chelation in VPS35 kd cells that 209 overexpressed the wt-VPS35 construct (Fig. 5E ). These experiments confirm that VPS35 210 regulates retrieval of ATP7B from lysosomes (and also possibly from late endosomes) to TGN 211 upon copper depletion. 228 Next, using biochemical assays to investigate if VPS35 directly interacts with ATP7B we utilized 229 co-immunoprecipitation where GFP-ATP7B was expressed in cells, pulled down with anti-GFP 230 beads and probed for endogenous VPS35. We failed to detect any signal in the immunoblot 231 developed with anti-VPS35 antibody (Fig. S4 ).
212

Lysosomal luminal pH does not influence localization of ATP7B and recruitment of VPS35
VPS35 acts on ATP7B in a micro-distant modus operandi
232
To understand the underlying reason of why we could not detect interaction between ATP7B 233 and VPS35 using biochemical methods, we resorted to Super resolution microscopy to Since, the interaction between ATP7B and VPS35 is likely to be indirect and possibly they a part 247 of a larger complex, we utilized Proximity Ligation Assay (PLA) to substantiate our finding.
248
Interaction of Hur and Trim21 (Guha et al., 2019) were used as used as positive controls and 249 secondary antibodies against ATP7B (anti-rabbit) and VPS35 (anti-goat) were used as negative 250 controls. We observed positive interaction between ATP7B and VPS35 that is evident by 251 formation of red intracellular puncta on sites if the two proteins juxtapose at a distance less than 252 <40nm ( Fig 7F) .
253
This finding strongly suggest that VPS35 and ATP7B are a part of a larger complex and the 254 regulation of ATP7B trafficking by the retromer proteins are possibly indirect and they do not 255 share a physical interface. To detect such an interaction, we metabolically labeled GFP-ATP7B 256 overexpressing HepG2 cells with Photo amino-acids (P-Leucine and P-Methionine). Cells were 257 treated with copper or copper chelator and subjected to UV crosslinking. Crosslinked GFP-258 ATP7B complex was immune-precipitated with anti-GFP beads. Upon probing the eluate on an 259 immunoblot with anti-VPS35, VPS26 and anti-GFP antibodies, a complex >> 250KDa was 260 detected that was comprised of all the three proteins. The complex was found to be absent or 261 much less abundant in cells treated with copper chelator, TTM ( Fig 7G) .
262
In summary we establish that, ATP7B traffics to lysosomes at high copper where it juxtaposes 263 with VPS35 and contributes to the formation of a complex that comprises of at least ATP7B, 264 VPS35 and VPS26 in addition to other proteins. Upon triggering the retrograde pathway by 265 subsequent copper chelation, retromer regulates the recycling of ATP7B from the lysosome to 266 the TGN (Fig. 8 ).
267
Discussion: 268 The copper transporting ATPase, ATP7B exports copper through lysosomes. ATP7B (160kDa) 269 is a large 8 membrane spanning protein with a total of 1465 residues. ATP7B resides on the 270 TGN membrane at basal copper levels and traffics to lysosomes and Rab7 compartments at 271 high copper. We argue that it would be highly wasteful for the cell to degrade ATP7B after each 272 cycle of copper export from the TGN to the lysosomes. We wondered whether ATP7B recycles 273 back from the lysosome after it pumps copper in the lysosomal lumen for either export out of the 274 cell or for reutilization as a nutrient that requires to be investigated. Interestingly, the protein 275 does not get degraded unlike most other cargoes that are destined for degradation at the Upon examining triple-colocalization of ATP7B, VPS35 and Lamp1 in fixed cells, we notice that 295 the level of overlap is moderate at high copper. This might be attributed to the fact that at a given 296 point in copper treated cells, the nature of vesicles are highly heterogeneous comprising of 297 retrograde and anterograde vesicles and that too at various stages of trafficking. We hypothesize 298 that the lysosomes would exhibit a higher co-residence of VPS35 and ATP7B if we are able to 299 synchronize the TGN exit (upon copper treatment) and lysosomal exit (upon subsequent copper 300 removal) of ATP7B. However, time lapse imaging showed that GFP-ATP7B and mCherry-Vps35 301 colocalizes in the compartment for a few minutes. In VPS35 kd cells, ATP7B is trapped in the 302 lysosomes even upon activating the retrograde pathway (Copper>BCS). We reason that ATP7B 303 recycles back to TGN from the lysosomes directly and not via plasma membrane as we did not 304 observe ATP7B staining at the plasma membrane or even at the cortical actin (data not shown). 305 Interestingly, we did not detect any direct interaction of ATP7B and VPS35 (or VPS26). This is 306 possibly due to the fact that though retromer complex regulates lysosomal exit of ATP7B, the 307 interaction is mediated via a different member of the complex. This proposition is substantiated 308 by co-detection of ATP7B, VPS35 and VPS26 in a supercomplex (>>250kDa) and also proximity 
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For STED sample preparation, HepG2 cells were seeded on glass coverslips, treated with BCS 390 and copper (as mentioned in Fig. 8E ). Treatment was done at 70% confluency. Cell were fixed 391 with 2% PFA for 20mins followed by washing with 1X PBS, pH 7.2 for 15mins (× 2) and then 392 quenched with 50mM NaCl. Blocking and permeation was done for 30mins with 1% BSA along 393 with 0.075% saponin. Cell were co-incubated with primary rabbit anti-ATP7B and goat anti- Technology, Sigma). Briefly, HepG2 cell was grown on glass coverslips upto 70% confluency 496 and treated with copper for 2hrs, fixed with 4% paraformaldehyde and permeabilized with 0.1% 497 saponin. Thereafter, cell was blocked with blocking solution (DUO82007) for 1hr at 37 0 C and 498 incubated with primary antibodies (as indicated in Fig.10 ) for 2hrs at 37 0 C followed by washing 499 twice with Wash Buffer A (DUO82049-4L) for 5mins on gentle orbital shaker at room temperature 500 (RT). During washing, the secondary PLA probes (DUO92005, DUO92003, DUO92001) were 501 diluted to 1:5 with antibody diluent (DUO82008) and cell was incubated with it for 1hr at 37 0 C.
502
Cell was further washed in same way. During washing, the ligation mixture was prepared by 503 diluting the ligase enzyme (DUO82029) 1:40 in 1X ligation buffer (DUO82009) and applied onto 504 cell. It was then incubated for 30mins at 37 0 C followed by washing twice in Wash buffer A for 505 2mins at RT. During washing, the amplification mixture was prepared by diluting the polymerase 
